The Anti-Leishmanial Drug Miltefosine Causes Insulin Resistance in Skeletal Muscle Cells in Vitro

Diabetologia - Germany
doi 10.1007/s00125-006-0260-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MDR1 Causes Resistance to the Antitumour Drug Miltefosine

British Journal of Cancer
Cancer ResearchOncology
2001English

Chemical and Bioassay Techniques to Authenticate Quality of the Anti-Leishmanial Drug Miltefosine

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2015English

Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance

Physiological Reviews
MedicinePhysiologyMolecular Biology
2006English

Glucose Infusion Causes Insulin Resistance in Skeletal Muscle of Rats Without Changes in Akt and AS160 Phosphorylation

American Journal of Physiology - Endocrinology and Metabolism
EndocrinologyPhysiologyMetabolismDiabetes
2007English

Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2015English

Mechanism of Increased Risk of Insulin Resistance in Aging Skeletal Muscle

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Mechanism of Amino Acid-Induced Skeletal Muscle Insulin Resistance in Humans

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Lactate Induces Insulin Resistance in Skeletal Muscle by Suppressing Glycolysis and Impairing Insulin Signaling

American Journal of Physiology - Endocrinology and Metabolism
EndocrinologyPhysiologyMetabolismDiabetes
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy